- Clinical Interests
- Drug hypersensitivity
- Medical Education
- MSC, Harvard University
- MD, Yale University School of Medicine
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Internal Medicine
- Allergy & Immunology
- Foreign Languages
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- OSW - Maine
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
Kimberly Blumenthal, MD, MSc has clinical and research expertise in drug allergy, and specific interest in antibiotic allergies. She is recognized nationally for having created innovative approaches to the evaluation of penicillin and cephalosporin antibiotic allergies in the hospital.
Dr. Blumenthal graduated from Columbia University with a BA in Economics (2002). She studied medicine at Yale University School of Medicine, which she completed in 2009, before training at the Massachusetts General Hospital for Internal Medicine and Allergy and Immunology.
- Research Summary
Dr. Blumenthal has funding from both the National Institutes of Health and the American Academy of Allergy, Asthma, and Immunology to study drug allergies. She has authored or co-authored over 20 peer-reviewed publications related to improving the care of patients with drug allergies.
Dr. Blumenthal performs epidemiology, informatics, outcomes and cost-effectiveness research in the field of drug allergy. Her past research evaluated both true drug hypersensitivity and the clinical impact of over-reported drug allergies on patients and healthcare systems, and includes over 20 original manuscripts. As part of her post-doctoral research, she designed, implemented and evaluated a hospital-wide guideline for antibiotic prescribing for patients with a reported β-lactam antibiotic allergy at Mass General. After successfully demonstrating the guideline’s safety, feasibility, and positive impact on antibiotic stewardship at two institutions, she led the implementation of this guideline at five Partners HealthCare hospitals.
Patients believed to be allergic to penicillin have significantly increased risks of MRSA and C. difficile
Analysis by Massachusetts General Hospital investigators of a large group of outpatient reveals that patients believed to be allergic to penicillin have significantly increased risks of contracting the dangerous infections MRSA and C. difficile.
A study by Massachusetts General Hospital investigators found that surgical patients believed to be allergic to penicillin were significantly more likely to develop surgical site infections than were patients with no documented allergy, a difference totally attributable to the alternative antibiotics used to prevent such infections.
55 Fruit Street
Boston, MA 02114-2696